ANI Pharmaceuticals Inc (ANIP)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 428,530 | 457,599 | 338,540 | 358,740 | 195,700 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $428,530K
= 0.00
ANI Pharmaceuticals Inc has consistently maintained a debt-to-equity ratio of 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has no debt in relation to its equity during this period. A debt-to-equity ratio of 0.00 typically suggests that the company is financing its operations primarily through equity rather than debt. While a low debt-to-equity ratio can indicate a lower financial risk, it is essential to consider the company's overall financial stability and capital structure in conjunction with other financial metrics for a comprehensive assessment.
Peer comparison
Dec 31, 2024